DongKook Pharmaceutical Co (XKRX:086450) EPS (Basic) : ₩1,073.00 (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is DongKook Pharmaceutical Co EPS (Basic)?

DongKook Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was ₩206.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,073.00.

DongKook Pharmaceutical Co's EPS (Diluted) for the three months ended in Dec. 2023 was ₩203.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,054.00.

DongKook Pharmaceutical Co's EPS without NRI for the three months ended in Dec. 2023 was ₩284.70. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 1,135.64.

During the past 12 months, DongKook Pharmaceutical Co's average EPS without NRIGrowth Rate was -12.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was -4.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 17.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, DongKook Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 73.80% per year. The lowest was -33.80% per year. And the median was 13.25% per year.

DongKook Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for DongKook Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DongKook Pharmaceutical Co EPS (Basic) Chart

DongKook Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

256.20

1,273.00

1,146.00

1,203.00

1,073.00

DongKook Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															213.00	365.00	226.00	276.00	206.00

DongKook Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

DongKook Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(47175.203	-	0)	/	43.966
	=	1,072.99

DongKook Pharmaceutical Co's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(9065.487	-	0)	/	43.983
	=	206.11

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,073.00

DongKook Pharmaceutical Co (XKRX:086450) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

DongKook Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of DongKook Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

DongKook Pharmaceutical Co (XKRX:086450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DongKook Pharmaceutical Co Ltd (XKRX:086450) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

Dongkook Building 997-8 Daechi 3-dong, Kangnam-gu, Seoul, KOR, 135-502

Website

http://www.dkpharm.co.kr

DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.

DongKook Pharmaceutical Co (XKRX:086450) Headlines

No Headlines